NEW YORK (GenomeWeb News) — Cisbio Bioassays will offer BioTrove's mass spectrometry screening service for assay development and drug screening to customers in the US, BioTrove said today.

Under the co-exclusive distribution agreement, Cisbio will offer BioTrove's RapidFire high-throughput service as a label-free detection method in conjunction with its Homogenous Time-Resolved Fluorescence, or HTRF technology and services. BioTrove will perform the RapidFire services at its screening facility.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.